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Abstract
Background: Frailty can be defined as a progressive loss of reserve and adaptive capacity associated with an overall
deterioration in health that can result in disability, loss of independence, hospitalisation, extensive use of healthcare
resources, admission to long-term care and death. Nevertheless, despite widespread use of the term, there is no
agreement on the definition of frailty or an instrument to identify it in a straightforward way. The purpose of the
current study was to explore which factors are associated with frailty-related adverse outcomes in elderly individuals
and to propose a suitable tool for identifying such individuals, particularly in primary care settings.
Methods: A prospective open cohort study of community dwelling, independent individuals aged 75 or over, followed
up for 2 years. The study was entirely conducted in a primary care setting. Study variables included independence status
measured by Barthel’s Index and the Lawton Instrumental Activities of Daily Living Scale, functional performance, assessed
by Timed Up and Go (TUG) and Gait Speed (GS) tests and levels of polipharmacy, comorbidity and social support.
Outcome variables were specific frailty-related adverse events, namely, loss of independence and death.
Results: Overall, 215 community-dwelling independent individuals initiated the study. Of these, 46 were lost to
follow-up and 50 had frailty-related adverse events during the follow-up period. Individuals with adverse
events during the study had poorer functional status at baseline. The multivariate model that best explained
the occurrence of these events included the variables of age, presence of polipharmacy and the TUG time.
The AUC (Area under the curve) of this model was 0.822.
Conclusions: Given the simplicity of assessing the three derived factors and their combined discriminant
power, the proposed model may be considered a suitable tool for identifying frail patients, i.e., people more
likely to lose their independence or die within a relatively short time interval.
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Background
Frailty can be defined as a progressive loss of reserve and
adaptive capacity associated with an overall deterioration
in health that can result in disability, loss of independence,
hospitalisation, extensive use of healthcare resources, ad-
mission to long-term care and death [1–3]. Nevertheless,
despite the widespread use of the term, there is no agree-
ment on the definition of frailty [4, 5] or on an instrument
to identify it [6] in a straightforward way, particularly in
primary care.
Three approaches for the identification of frail indi-
viduals have been described in the literature [7]: the
rules-based, the cumulative and the clinical judgment.
Rules-based approaches are derived from multiple
regression models and are based on the presence of a
number of symptoms. The phenotypic approach would
be included in this group [1]. Cumulative-based
approaches are based on the consideration and addition
of the number of impairments presented by a single
person [8]. Finally, clinical judgment based approaches
rely on the professional interpretation of the clinical
record and physical examinations [7].
A frequently considered aspect in the aforementioned
approaches is functional performance. Several instruments
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have been proposed to assess various aspects of functional
performance such as motor strength, mobility and bal-
ance. Those most commonly used being the Timed Up
and Go (TUG) [9, 10] and Gait Speed (GS) tests [11, 12].
Such tests have demonstrated their usefulness in terms of
monitoring the health status, functional capacity and risk
of falls of elderly people [11, 13–15].
Early identification of frail individuals in primary care
could have a double impact. On the one hand, it may help
improve the health status of identified individuals, since it
would be possible to address their needs in a comprehen-
sive manner, delaying or preventing the natural progression
towards dependence [16]. On the other hand, it may lead
to reductions in resources use [2].
The objective of this study was to assess which factors
are associated with frailty-related adverse outcomes in
elderly individuals and on the basis of these results and
from a rules-based perspective, to propose a suitable
instrument for identifying these patients in primary care.
Methods
Study population and recruitment
An open cohort of community-dwelling individuals, aged
75 years or more and independent (Barthel’s index ≥90) at
the time of inclusion. Patients of advanced age were
selected in order to assure a rate of occurrence of the
defined adverse outcomes, adequate to the project design
and span [17, 18]. Recruitment took place in the primary
care centres of two municipalities in Gipuzkoa (Spain)
and subjects were followed up for 2 years. The partici-
pating health centres are situated in an urban area close
to the provincial capital (San Sebastian) and their popu-
lation characteristics are similar to the Basque Country
region in terms of age, sex and deprivation index [19].
These centres provide primary care services to a total
adult population of around 30,000 individuals. The
study was carried out between July 2010 and December
2013.
Eligible individuals were selected randomly from admin-
istrative databases in order to obtain a representative sam-
ple of the reference population in terms of age and sex.
After being informed about the study by their correspond-
ing primary care doctors they were invited to a meeting
where detailed information about the research project was
presented and informed consent was provided. The study
was approved by the Clinical research ethics committee of
the Gipuzkoa health region (ref.: 05/2010).
Individuals were excluded from the study if they
were institutionalised, planned to move within the fol-
lowing 2 years or were included in a home care
programme for chronic health problems. Patients with
impaired cognitive function, defined as 5 or more
errors on the Pfeiffer’s Short Portable Mental Status
Questionnaire [20, 21], and those who were dependant,
defined as a score <90 in the Barthel’s index [22] were also
excluded. All participants provided informed consent.
Study variables
As main outcome variables were considered the events
of death and loss of independence; the latter defined as
loss of ≥ of 10 % of the baseline Barthel score during the
study follow-up period, considering that this reduction
on Barthel score imply the loss of independence in pre-
forming a basic daily living activity [23–27].
Interviews were performed on an individual basis and
information collected at baseline included among others:
age, sex, level of education, living arrangements, and
social risk measured using the Gijon Scale [28]. To
assess participants’ functional status, the Lawton Instru-
mental Activities of Daily Living (IADL) Scale [23, 29]
and two physical functional performance tests (TUG
and GS) [9, 11] were used. To assess overall health
status, information was requested regarding loss in body
weight, level of physical exercise, sensory deficits includ-
ing hearing impairment, and self-perceived health using
the following question: “How would you rate your
health?”
Additionally, health records were reviewed to detect
any falls and hospital admissions in the previous year; to
confirm the presence/absence of polipharmacy, defined
as the simultaneous prescription of 4 or more drugs
continuously for 3 or more months [30]; and/or comor-
bidity, defined as three or more of the following condi-
tions: stroke with sequelae, myocardial infarction or
recently diagnosed heart failure, Parkinson’s disease,
chronic obstructive pulmonary disease, musculoskeletal
disorders resulting in pain or functional impairment,
diabetes mellitus treated orally or with insulin, neuro-
logical gait disorders, unresolved urinary complaints,
and mental illness under treatment with psychoactive
medication [31]. The interviews and review of health
records were carried out by two nurses trained for the
purpose.
Follow-up
Every six months from the date of recruitment and over
the 2 years of follow-up, patients were appointed for an
additional assessment. These assessments included all
the aforementioned functional and daily activity mea-
sures (Barthel’s index, Lawton’s scale, TUG and GS tests)
and information about weight, physical exercise, sensory
deficits and self-perceived health. The corresponding
nurse was contacting patients not attending a follow-up
assessment visit. Those stating that they lost interest in
the study were considered drop-outs. Patients who lost
independence and had to be admitted to an older peo-
ple’s home were registered as dependent. If the family
took care of the dependent individuals, Barthel values
Diez-Ruiz et al. BMC Geriatrics  (2016) 16:91 Page 2 of 8
were also collected by interviewing the person responsible
to provide for them. Death events were verified by medical
records. Patients who could not be located and did not
come back for the rest of the assessments were considered
drop-outs. Patients, who returned after missing certain
assessments, were kept in the final sample and were
assigned in the corresponding outcome group. No missing
values imputation was performed for the needs of this
study.
Sample size
Loss of independence and mortality rates in subjects over
75-years of age were reviewed in previous studies in our
setting (non-published data). Obtained estimates were
equal to 18 and 5 % respectively. Assuming a dropout rate
of 10 % during the follow-up period, we calculated that
with n = 200 participants we could expect around 40
individuals to lose their independence by the end of the
study. Given the binary nature of the considered out-
come (deterioration Yes/No), applying the rule of
thumb of 10 events per variable this sample size would
enable us to construct binary logistic regression models
including simultaneously 4 to 5 predictive factors,
should results indicate that many factors to be relevant.
Statistical analysis
The unit of analysis was the patient. Descriptive statistics
were used to analyse dependent and independent variables
at baseline and each follow-up assessment. Frequencies
and percentages were calculated for categorical data and
means and standard deviations (SD) or medians and inter-
quartile ranges (Q1, Q3) for continuous data, depending
on their distribution. Categorical variables were compared
with chi-squared or Fisher’s exact tests while Student’s t-
test or the non-parametric Wilcoxon were implemented
for normally and non-normally distributed continuous
variables.
In order to assess whether missing data were random
or were associated with specific patient characteristics,
socio-demographic and clinical characteristics variables
were compared between lost to follow-up individuals
and those who completed the follow-up. Finally, univari-
ate and multivariate binary logistic regression models
were constructed to assess the relationship between each
of the independent variables and the occurrence of the
frailty-related adverse events under study. All variables
with significance levels p ≤ 0.10 in the univariate analysis
were considered for the construction of the multivariate
model. At this stage both backward and forward step-
wise models were tested. In the backward procedure all
relevant variables entered in the same model. Non-
significant variables were eliminated one-by-one, based
on their p-values (eliminating the less significant first),
until no p-value >0.05 were left in the model. In the
forward procedure, the most significant variable entered
in the model, followed by the next more significant etc.,
eliminating those with p-value > 0.05 [32].
In a secondary stage sensitivity analyses were per-
formed. Further multivariate models were fitted, making
different assumptions about the drop-out patients. In
particular it was assumed that: a) all lost to follow-up
had a negative outcome; b) all lost to follow up had a
positive outcome; c) those not located had a negative
outcome and finally d) those not located had a positive
outcome.
The diagnostic performance and goodness-of-fit statis-
tics were studied for all constructed models. The results
of the final model are presented in terms of odds ratios
(OR) with corresponding 95 % confidence intervals (CI).
The area under the curve (AUC), Hosmer-Lemeshow
statistic and R-square values are also reported. Results
were considered statistically significant when p <0.05.
All analyses were performed with the SAS 9.3 software.
Results
A total of n = 215 individuals were initially included in
the study and of those n = 169 completed the proposed
follow-up. No significant differences were found in
terms of socio-demographic and clinical characteristics
between lost to follow-up subjects and those who com-
pleted the study. At the end of the follow-up period, n
= 119 subjects remained independent, while the other
n = 50 participants (24 %) had a frailty-related adverse
outcome: death (n = 8) or loss of independence (n = 42)
(Fig. 1). The rates of independence loss in the first and
second years were 8.3 and 2.6 %, respectively.
At baseline, participants had a mean age of 79.4
(SD: 4.1) years and 63 % were women. A high pro-
portion of subjects presented comorbidity (72 %) and
polipharmacy (61 %). Comparing the baseline status
of those who eventually developed a frailty-related
adverse outcome and those who did not, we observed
the following. The adverse outcome group was on
average 3 years older (p < 0.001), had a lower level of
physical activity (p = 0.001) and was more likely to
present polipharmacy (p = 0.001) or comorbidity (p =
0.032). In addition, it presented more hospital admis-
sions in the previous year (p = 0.013) and declared a
poorer self-perceived health status. No significant dif-
ferences were found in the variables of sex, body
mass index, visual or auditory deficits and accidental
falls in the previous year (Table 1).
As far as functional status is concerned, participants
who developed frailty-related adverse outcomes, despite
being independent at baseline, had lower levels of func-
tioning in terms of basic activities of daily living
(Barthel’s index) and IADL (Lawton’s score). Significant
differences were also observed in the functional
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performance tests of TUG and GS at baseline. Participants
with frailty-related adverse outcomes performed worse in
both (p < 0.001) (Table 2). No socio-demographic differ-
ences were observed between those finishing the study
and drop-out subjects. The latter were half a year older
than the rest (mean drop-out age 79.9 (SD: 4.0), p =
0.398); 39 % of them were men, compared to 36 % of
those completing the study (p = 0.705). Both groups had
similar baseline Barthel values (p = 0.901) and self-
perceived health (p = 0.218).
Except for Barthel and Lawton scales, all other vari-
ables with p-values ≤0.10 presented in Tables 1 and 2
were implemented in the construction of the multivari-
ate logistic regression model. It’s worth mentioning that
due to their high correlation (r = −0.821), GS and TUG
could not be both considered in the same model and the
TUG was selected given its capacities [33]. Furthermore,
the presence of comorbidity and having specific health
problems (e.g., musculoskeletal disorders) were not sig-
nificant in any of the models that included the poliphar-
macy variable, possibly due to the strong association
between these factors. Both the forward and backward
stepwise regressions resulted in the same multivariate
model.
The multivariate logistic regression model that best
fitted the data included age (OR: 1.14; 95 % CI: 1.03,
1.25), polipharmacy status (OR: 2.74; 95 % CI: 1.06,
7.06) and TUG time (in seconds) (OR: 1.28, 95 % CI:
1.14, 1.44) (Table 3). Our results suggest that these fac-
tors have good discriminant validity, with an area under
the curve (AUC) of 0.822 (Fig. 2), adjusted R-squared
of 0.384 and Hosmer Lemeshow p = 0.721 (Table 3).
The additional sensitivity analyses gave the follow-
ing results. When all lost to follow-up (n = 46) were
assumed to be finally dependent, the derived model
included the variables of age, TUG and at least one
hospital admission in the last year. When only those
not located (n = 29) were considered dependent, the
model included age and TUG. When all lost to
follow-up (n = 46) or only those not located (n = 29)
were assumed to be independent, the final models in-
cluded the variables of age, TUG and polipharmacy.
Fig. 1 Flow chart of patient recruitment and follow-up
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The AUCs of all four models oscillated between 0.733
and 0.795.
Discussion
Proper identification of frail individuals in primary care
represents an unresolved challenge. The current study,
leaving aside discussions on the definition of frailty and
its components, addresses this issue from a pragmatic
point of view. Subjects able to perform basic daily living
activities (BADL), so independent, are considered frail
when they lose independence or die in a maximum
period of two years. With this approach, the prevalence
Table 1 Baseline data of the entire sample and comparison between the two groups of adverse events
Adverse event
Baseline variables Total (N = 215) Yes (n = 50) No (n = 119) p-value
Age; mean (SD) 79.4 (4.1) 81.7 (4.6) 78.4 (3.5) <0.001
Sex: Female 136 (63) 32 (64) 76 (64) 0.987
Able to read and write 205 (95) 47 (94) 114 (96) 0.695
Living with spouse of family member 162 (75) 35 (70) 88 (74) 0.599
Weight loss in the last yearb 18 (8) 6 (12) 5 (4) 0.085
Low level of physical activity 22 (10) 11 (22) 6 (5) 0.001
Polipharmacy 131 (61) 41 (82) 65 (55) 0.001
Fall in the previous year 52 (24) 12 (24) 30 (25) 0.868
Hospital admission in the previous year 36 (17) 13 (26) 13 (11) 0.013
Self-perceived health
Good/very good 136 (63) 26 (52) 91 (77) 0.003
Fair 73 (34) 23 (46) 26 (22)
Poor/very poor 7 (3) 1 (2) 2 (1)
Social risk (Gijon); median (Q1, Q3) 10 (9, 12) 10 (8, 12) 10 (9, 12) 0.442
Comorbidity: Yes 153 (72) 35 (70) 62 (52) 0.032
Presence of health problems a
Body mass index >30 kg/m2 63 (29) 18 (36) 33 (28) 0.285
Musculoskeletal disorders 52 (24) 17 (34) 21 (18) 0.020
Diabetes under treatment 37 (17) 8 (16) 23 (19) 0.610
Chronic obstructive pulmonary diseaseb 12 (6) 6 (12) 1 (1) 0.003
Visual deficit b 8 (4) 3 (6) 2 (1) 0.154
Auditory deficit b 6 (3) 1 (2) 4 (4) 1.000
Adverse event: death or loss of independence defined as ≥10 % drop in Barthel’s score compared to baseline, during the follow-up. Data are expressed as frequencies
(percentages), unless otherwise stated. For dichotomous variables one of the two categories are presented.
aPresented health problems are not exclusive; a patient can suffer by more than one. P values in the last column refer to comparisons between the groups with
and without adverse events (Yes vs. No). Age was compared with Student’s t test
bthese variables were compared with Fisher’s exact test, the Chi-square test was implemented for the rest of the variables
Table 2 Baseline data on functioning and comparison between groups with and without adverse frailty-related outcomes
Adverse event
Functional tests Yes (n = 50) No (n = 119) p-value
Barthel’s index; n (%)
90 points 16 (32) 7 (6) <0.001
95–100 points 34 (68) 112 (94)
Lawton IADL; median (Q1, Q3) 6 (4, 8) 8 (5, 8) <0.001
Timed Up and Go time, s; median (Q1, Q3) 15 (13, 22) 12.5 (11, 14) <0.001
Gait Speed, m/s.; mean (SD) 0.8 (0.2) 1.1 (0.2) <0.001
Categorical variables were compared with the chi-squared test; means and medians were compared using the Student’s t and Wilcoxon tests, respectively
Adverse event death or loss of independence defined as ≥10 % drop in Barthel’s score compared to baseline, during the follow-up, IADL Instrumental activities of
daily living. The abbreviations: s and m/s indicate seconds and meters per second respectively. Q1, Q3 interquartile range from the first to the third quartile, SD
standard deviation
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of frailty in our sample would be 24 %, higher than
expected in our setting, but in agreement with other
published studies [4, 34].
Our study shows that it is possible to identify clear dif-
ferences between groups of community-dwelling elderly
individuals that do and do not lose their independence
within 2 years. The differences are significant in terms of
age, level of physical activity, health status and functional
capacity. The current results are in agreement with the
literature on this topic, indicating association between
frailty with age, comorbidity, self-perceived health and
functional status [35]. No differences in terms of socio-
economic status, or family and social network were
found in our sample.
Considering the prospective nature of the method-
ology used in this study and the rules-based approach
proposed for the construction of operational definitions
of frailty, we found that the factors associated with
frailty-related adverse outcomes could be expressed in a
single model including age, polipharmacy status and
TUG time. We should underline that when constructing
the model polipharmacy was selected over other
comorbidity-related variables, as it is easier to assess
than other comorbidity indices. As stated in the results
section, none of these other variables was statistically
significant when considered simultaneously with poli-
pharmacy, most likely due to the existing relations
between them. The sensitivity analyses performed seems
to support the presented model. Even though hospital
admission turned out to be significant, when all drop-
outs were considered dependent, it is a fact that hospital
admission and polipharmacy are not independent, rather
highly related variables. Recent hospital admission may
be indicative of a health problem which can end up in a
negative outcome and has been often described as asso-
ciated to frailty [36]. A high association between the two
was also found in our in our sample (p = 0.002).
To date, a variety of approaches have been suggested
for identifying frail individuals. One well-known
approach uses the frailty phenotype proposed by Fried
in 2001 [1], based on the presence of at least three of
the following deficits: slow gait speed, weak grip
strength, low level of physical activity, exhaustion and
unintentional weight loss. Despite the widespread use
of this phenotype in research, this tool has not been
widely adopted in clinical practice, possibly due to the
lack of population studies establishing diagnostic cut-
offs for some of the criteria [3]. Other ways of identify-
ing frail individuals involve frailty indices, based on
cumulative approaches [37]. Indices published in recent
years include the Survey of Health, Ageing and Retire-
ment in Europe (SHARE) Frailty Instrument [38, 39],
and the Program of Research to Integrate Services for
the Maintenance of Autonomy (PRISMA) questionnaire
[40]. These indices assess the existence of deficits in
areas such as strength, balance, nutrition, resistance,
mobility, physical activity and cognitive ability, but
none of them have been taken up in primary care set-
tings. Also, a third approach based on the clinical judg-
ment it’s being explored. In this group, the Gérontopôle
Frailty Screening Tool [41] and the EASY-Care TOS
[42, 43] can be considered. The latter, with a specific
Table 3 Multivariate logistic regression model for the onset of
adverse events related to frailty
Variable Odds ratio 95 % CI p-value
Age, years 1.14 1.03, 1.25 0.012
Timed Up and Go time, s 1.28 1.14, 1.44 <0.001
Polipharmacy
No Ref – –
Yes 2.74 1.06, 7.06 0.037
Goodness-of-fit statistics
Area under the curve: 0.822
R squared / adjusted R squared: 0.270/ 0.384
Hosmer-Lemeshow: p = 0.721
The probability of suffering a frailty-related adverse event during the follow-up
period was modelled. Adverse event: death or loss of independence defined
as ≥10 % drop in Barthel’s score compared to baseline, during the follow-up,
95 % CI: 95 % confidence interval. Polypharmacy: long-term prescription of ≥ 4
drugs. The model is based on n = 50 adverse events and n = 118 positive
events due to 1 missing value in TUG test
Fig. 2 ROC of the proposed model for identifying frailty in primary care.
Receiver operating characteristic curve for the final model to
predict frailty-related outcomes, based on age, Timed Up and Go
time and polypharmacy status. The curve represents the relationship
between sensitivity and 1-specificity for all potential cut-off points of
the diagnostic test under study. The area under the curve (AUC), a
measure of the discriminatory power of the test, is 0.822. The cut-off
point that maximises sensitivity and specificity (i.e., 76 %) is 0.288
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focus on primary care settings, provides a robust and
easy to perform two step tool for the identification of
frail patients in primary care practices. It is interesting
to note the parallelisms with this article especially re-
garding aim (primary care oriented) and methodology
(longitudinal, adverse outcome based). Nevertheless,
the main difference is the implemented frailty identifi-
cation approach. Our tool is a rules-based one while
EASY-Care TOs is based on clinical judgment. Add-
itionally, our proposal overcomes one of the main
limitations of the clinical judgment based tools, which
is that they rely on a strong and long term patient –
care professional relationship, whereas the proposed
tool is based on three objective and easy to measure
variables, not requiring previous knowledge of the pa-
tient’s clinical history. Hence, given the characteristics
and simplicity of our model, we believe that once val-
idated in a different and broader population, it could
be considered as a screening test for identifying frail
individuals in primary care.
The main limitation of our study is related to its
cohort design and associated losses to follow-up. To
minimise this bias, we thoroughly informed patients
about the goals of the research, arranged informative
meetings with them and carried out a campaign to raise
awareness of the study in the participating health cen-
tres. There were more losses during the follow-up
period than expected, but figures were similar to those
of other studies and are considered acceptable [44]; fur-
ther, we reached the number of frailty-related adverse
outcomes expected, which has enabled us to achieve the
desired robustness in the analysis. Another notable limi-
tation is the fact that repeating performance tests may
lead to a certain degree of training. In any case, this
limitation would underestimate the onset of functional
deterioration and hence would not affect the validity of
the results [45]. To minimise bias from inter-observer dif-
ferences, we standardised the criteria for the administra-
tion of the various different scales and tests and trained
the nurses in charge of data collection.
The main strength of this study is the fact that it was
conducted entirely in a primary care setting. Many stud-
ies in this field are conducted in geriatric settings, where
population characteristics and patient needs are very dif-
ferent. A recently initiated research project (reference
PI14/01905) will allow us to further validate the ability
of the proposed model in identifying frail individuals in
a larger sample of independent community dwelling
elders aged 70 or more.
Conclusions
It is possible to identify frail individuals considering their
age, polipharmacy status and functional capacity. These
three factors can be assessed in a simple and quick way,
fact which renders the proposed model suitable to use in
primary care.
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